OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Gedeon Richter Ltd/  HU0000123096  /

Nasdaq Other OTC
29/04/2024  20:48:49 Chg. +0.4200 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
28.1900USD +1.51% 1
Turnover: 28.1900		 -Bid Size: - -Ask Size: - 5 bill.USD - -
GlobeNewswire 03/05 Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the c...
GlobeNewswire 25/03 Gedeon Richter Selects Trial Interactive for Clinical Trial Management
GlobeNewswire 11/09/2023 Letter to Shareholders and Corporate Update
GlobeNewswire 26/01/2022 Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire 10/01/2022 Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
GlobeNewswire 26/10/2021 Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Up...
GlobeNewswire 28/07/2021 Myovant Sciences Announces Financial Results for First Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire 20/07/2021 Myovant Sciences Announces European Commission Approval for RYEQO® for the Treatment of Women With U...
GlobeNewswire 21/05/2021 Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Tr...
GlobeNewswire 11/05/2021 Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fis...
GlobeNewswire 11/02/2021 Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year ...
GlobeNewswire 12/11/2020 Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 20...
GlobeNewswire 11/08/2020 Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 202...
GlobeNewswire 18/05/2020 Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Q...
GlobeNewswire 31/03/2020 Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugoli...
GlobeNewswire 05/07/2019 Global Osteoporosis Market & Drug Outlook 2017-2027: Current Market Leader Prolia Will Make Way for ...
GlobeNewswire 13/06/2019 Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
GlobeNewswire 05/03/2019 Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Yea...
GlobeNewswire 01/03/2019 Mithra Reports 2018 Annual Results
GlobeNewswire 05/02/2019 Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other ...
GlobeNewswire 23/01/2019 Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 3...
GlobeNewswire 11/01/2019 Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including...
GlobeNewswire 02/01/2019 Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construc...
GlobeNewswire 18/12/2018 Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Exce...
GlobeNewswire 12/12/2018 Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreeme...